News
Metal Flower - Mark 3 (J) By Shawn Saris, Jon Ryan, Max Roberts, +4.2k more updated Jan 10, 2024 + − ...
Objective The FOURIER trial showed a benefit of the PCSK9 inhibitor evolocumab over placebo with respect to cardiovascular outcomes in patients with cardiovascular disease. However, we observed some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback